News

Hosted on MSN2mon
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings - MSN
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
mic5mon
Johnson and Johnson's Nasal Spray For Depression? FDA Gives Approval - Mic
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first standalone therapy for adults suffering from major depressive disorder ...
NBC New York5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC New York
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
Fox Business5mon
J&J's ketamine-derived nasal spray approved by FDA to treat depression - Fox Business
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
Fast Company5mon
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings - Fast Company
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder.
NBC 7 San Diego5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC 7 San Diego
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
New York Post5mon
J&J's ketamine-derived nasal spray approved by FDA to treat depression - New York Post
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
NBC DFW5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC 5 Dallas-Fort Worth
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The ...
NBC Connecticut5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC Connecticut
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
NBC Bay Area5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC Bay Area
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The ...
NBC Los Angeles5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC Los Angeles
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The ...